| |
Symbol |
Name |
Market Cap |
Exchange |
Z-Score |
 | ABT  | Abbott Laboratories | $76.1B | NYSE | 2.9502 |
| ACST | Acasti Pharma Inc | $13.5M | NASDAQ | |
| ACET | Aceto Corporation | $424.6M | NASDAQ | 3.1677 |
| ADMP | Adamis Pharmaceuticals Corp | $78.3M | NASDAQ | 0.6003 |
| AEGR | Aegerion Pharmaceuticals, Inc. | $56.6M | NASDAQ | -0.2894 |
| AKRX | Akorn, Inc. | $4.2B | NASDAQ | 3.2681 |
| AMAG | AMAG Pharmaceuticals, Inc. | $667.9M | NASDAQ | 0.499 |
| FOLD | Amicus Therapeutics, Inc. | $1.0B | NASDAQ | 0.1665 |
| AMPH | Amphastar Pharmaceuticals Inc | $743.8M | NASDAQ | 5.7008 |
| APRI | Apricus Biosciences Inc | $14.0M | NASDAQ | -94.2731 |
| AQXP | Aquinox Pharmaceuticals Inc | $251.4M | NASDAQ | 14.906 |
| ARLZ | Aralez Pharmaceuticals Inc | $102.7M | NASDAQ | |
| AZN | AstraZeneca plc (ADR) | $42.8B | NYSE | 1.0932 |
| BDSI | BioDelivery Sciences International, Inc. | $101.8M | NASDAQ | -6.605 |
| BLFS | BioLife Solutions Inc | $29.1M | NASDAQ | -7.3448 |
| BMY | Bristol-Myers Squibb Co | $90.8B | NYSE | 5.2435 |
| CBM | Cambrex Corporation | $1.7B | NYSE | 6.7914 |
| CTLT | Catalent Inc | $4.0B | NYSE | 1.2594 |
| CLRB | Cellectar Biosciences Inc | $17.2M | NASDAQ | 0.166 |
| CPHR | Cipher Pharmaceuticals Inc | $77.8M | NASDAQ | |
| COLL | Collegium Pharmaceutical Inc | $221.7M | NASDAQ | 3.9724 |
| CLCD | CoLucid Pharmaceuticals Inc | $895.6M | NASDAQ | 76.7748 |
| CXRX | Concordia International Corp | $76.1M | NASDAQ | |
| CORT | Corcept Therapeutics Incorporated | $1.2B | NASDAQ | 20.6599 |
| CORI | Corium International Inc | $165.1M | NASDAQ | -0.7443 |
| RDY | Dr.Reddy's Laboratories Ltd (ADR) | $6.9B | NYSE | 1.7863 |
| LLY | Eli Lilly and Co | $88.2B | NYSE | 3.3818 |
| EVOK | Evoke Pharma Inc | $39.5M | NASDAQ | -3.5394 |
| EYEG | Eyegate Pharmaceuticals Inc | $18.5M | NASDAQ | -10.5269 |
| GALE | Galena Biopharma Inc | $21.2M | NASDAQ | -5.9726 |
| GSK | GlaxoSmithKline plc (ADR) | $107.1B | NYSE | 1.4541 |
| HSGX | Histogenics Corp | $22.3M | NASDAQ | -5.564 |
| HZNP | Horizon Pharma PLC | $1.7B | NASDAQ | 0.4013 |
| IBIO | Ibio Inc | $33.9M | NYSE MKT | -0.5538 |
| IMNP | Immune Pharmaceuticals Inc | $23.1M | NASDAQ | -1.9669 |
| IPXL | Impax Laboratories Inc | $1.3B | NASDAQ | 1.378 |
| INNL | Innocoll Holdings PLC | $64.1M | NASDAQ | -6.2078 |
| INVA | Innoviva Inc | $1.3B | NASDAQ | -4.0494 |
| IPCI | IntelliPharmaCeutics Intl Inc (USA) | $52.6M | NASDAQ | -5.9623 |
| JNJ | Johnson & Johnson | $336.3B | NYSE | 4.7797 |
| JNP | Juniper Pharmaceuticals Inc | $47.7M | NASDAQ | -2.7635 |
| LCI | Lannett Company, Inc. | $841.7M | NYSE | 1.1642 |
| MRNS | Marinus Pharmaceuticals Inc | $26.0M | NASDAQ | -3.1882 |
| MRK | Merck & Co., Inc. | $174.8B | NYSE | 3.1269 |
| MBRX | Moleculin Biotech Inc | $13.9M | NASDAQ | 5.7208 |
| MYL | Mylan NV | $19.8B | NASDAQ | 1.7764 |
| NAII | Natural Alternatives International, Inc. | $67.0M | NASDAQ | 4.8106 |
| NEOS | Neos Therapeutics Inc | $121.3M | NASDAQ | -1.9883 |
| NEOT | Neothetics Inc | $29.7M | NASDAQ | 7.1234 |
| CUR | Neuralstem, Inc. | $47.7M | NASDAQ | -8.6962 |
| NVS | Novartis AG (ADR) | $190.7B | NYSE | 3.3441 |
| NVO | Novo Nordisk A/S (ADR) | $80.0B | NYSE | 2.8662 |
| OPK | Opko Health Inc. | $4.0B | NASDAQ | 3.6819 |
| PCRX | Pacira Pharmaceuticals Inc | $1.9B | NASDAQ | 6.7727 |
| PTHN | Patheon NV | $3.7B | NYSE | 1.1773 |
| PTX | Pernix Therapeutics Holdings Inc | $55.6M | NASDAQ | -1.0909 |
| PFE | Pfizer Inc. | $197.1B | NYSE | 2.0001 |
| SGNT | Sagent Pharmaceuticals Inc | $346.4M | NASDAQ | 2.9821 |
| SNY | Sanofi SA (ADR) | $62.5B | NYSE | 1.2416 |
| SCLN | SciClone Pharmaceuticals, Inc. | $484.4M | NASDAQ | 11.9424 |
| SCYX | SCYNEXIS Inc | $43.6M | NASDAQ | -2.0495 |
| SHPG | Shire PLC (ADR) | $54.8B | NASDAQ | 1.1519 |
| SPHS | Sophiris Bio Inc | $77.2M | NASDAQ | |
| TARO | Taro Pharmaceutical Industries Ltd. | $4.9B | NYSE | 14.1186 |
| TLGT | Teligent Inc | $471.0M | NASDAQ | 2.8297 |
| TTPH | Tetraphase Pharmaceuticals Inc | $291.0M | NASDAQ | 12.9052 |
| TEVA | Teva Pharmaceutical Industries Ltd (ADR) | $32.2B | NYSE | 0.7429 |
| TBPH | Theravance Biopharma Inc | $1.8B | NASDAQ | 3.6204 |
| UG | United-Guardian, Inc. | $64.7M | NASDAQ | 39.9583 |
| VRX | Valeant Pharmaceuticals Intl Inc | $4.6B | NYSE | 0.1644 |
= link to the company website, 
